Guillain-Barre Syndrome – Talk Bio

Actionable Insights Powered by AI

Impact of New CDC Guidelines on RSV Vaccine Makers

9 months ago talkbio0Tagged Centers for Disease Control and Prevention (U.S.), Guidelines, Guillain-Barre Syndrome, Maker (occupation), Moderna, Pfizer, Recommendation, Respiratory Syncytial Virus Vaccines, SmithKline Beecham, Vaccination, Vaccines

RSV vaccine, CDC guidelines, vaccine makers, Moderna, Pfizer, GSK, Guillain-Barré syndrome, vaccination recommendations

Annexon Shares Soar as ANX005 Meets Primary Endpoint in Phase 3 Trial for Guillain-Barré Syndrome

11 months ago talkbio0Tagged Annexon, ANX005, Disability, Guillain-Barre Syndrome, Phase 3 trial, Prices, Primary Endpoint, Sharing (Social Behavior), surge

Annexon, ANX005, Guillain-Barré Syndrome, Phase 3 Trial, Primary Endpoint, Disability Reduction, Share Price Surge